LHC Group (LHCG) Downgraded by Zacks Investment Research
LHC Group (NASDAQ:LHCG) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a research report issued to clients and investors on Thursday.
According to Zacks, “LHC Group provides post-acute healthcare services primarily to Medicare beneficiaries in rural markets in the southern United States. They provide home-based services through their home nursing agencies and hospices and facility-based services through their long-term acute care hospitals and outpatient rehabilitation clinics. “
A number of other research firms have also recently issued reports on LHCG. Royal Bank Of Canada cut LHC Group from an “outperform” rating to a “sector perform” rating and raised their target price for the company from $44.00 to $58.00 in a research note on Friday, March 10th. Craig Hallum set a $57.00 price target on LHC Group and gave the company a “buy” rating in a report on Saturday, March 11th. Oppenheimer Holdings, Inc. reissued an “outperform” rating and set a $68.00 price target (up from $55.00) on shares of LHC Group in a report on Monday, May 8th. SunTrust Banks, Inc. raised LHC Group from a “hold” rating to a “buy” rating and raised their price target for the company from $50.00 to $56.00 in a report on Friday, March 10th. Finally, Jefferies Group LLC lifted their target price on LHC Group from $56.00 to $65.00 and gave the stock a “buy” rating in a report on Monday, May 15th. One analyst has rated the stock with a hold rating and seven have assigned a buy rating to the company. The stock presently has a consensus rating of “Buy” and a consensus price target of $64.38.
Shares of LHC Group (LHCG) traded up 1.25% during trading on Thursday, reaching $66.48. 78,091 shares of the company’s stock traded hands. LHC Group has a 1-year low of $32.04 and a 1-year high of $69.35. The company has a 50 day moving average of $63.33 and a 200-day moving average of $53.11. The company has a market capitalization of $1.22 billion, a price-to-earnings ratio of 30.78 and a beta of 0.80.
In related news, Director Coliseum Capital Management, L sold 128,000 shares of LHC Group stock in a transaction dated Thursday, May 11th. The stock was sold at an average price of $60.99, for a total value of $7,806,720.00. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, COO Donald Dwayne Stelly sold 3,181 shares of LHC Group stock in a transaction dated Thursday, June 8th. The stock was sold at an average price of $64.97, for a total value of $206,669.57. Following the completion of the transaction, the chief operating officer now directly owns 114,235 shares in the company, valued at approximately $7,421,847.95. The disclosure for this sale can be found here. Insiders sold a total of 682,839 shares of company stock worth $42,140,531 in the last three months. 14.80% of the stock is currently owned by company insiders.
Institutional investors have recently modified their holdings of the company. Russell Investments Group Ltd. bought a new position in shares of LHC Group during the fourth quarter worth $1,535,000. Swiss National Bank raised its stake in shares of LHC Group by 2.8% in the first quarter. Swiss National Bank now owns 25,535 shares of the health services provider’s stock worth $1,376,000 after buying an additional 700 shares during the last quarter. Norges Bank acquired a new stake in shares of LHC Group during the fourth quarter worth approximately $7,913,000. Sawgrass Asset Management LLC acquired a new stake in shares of LHC Group during the first quarter worth approximately $241,000. Finally, State Street Corp raised its stake in shares of LHC Group by 7.8% in the fourth quarter. State Street Corp now owns 373,936 shares of the health services provider’s stock worth $17,094,000 after buying an additional 26,915 shares during the last quarter. 84.75% of the stock is currently owned by hedge funds and other institutional investors.
LHC Group Company Profile
LHC Group, Inc is a holding company. The Company provides post-acute healthcare services to patients through its home nursing agencies, hospice agencies, community-based services agencies and long-term acute care hospitals (LTACHs). The Company operates through four segments: home health services, hospice services, community-based services and facility-based services.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for LHC Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LHC Group and related companies with MarketBeat.com's FREE daily email newsletter.